i nā lā i hala iho nei, ua nui nā mea kūʻai aku e nīnau iā semaglutide, he aha ia?
e ʻike iā ia -
ʻO Semaglutide kahi lāʻau antidiabetic i hoʻohana ʻia no ka mālama ʻana i ka maʻi diabetes type 2 a me kahi lāʻau anti-obesity i hoʻohana ʻia no ka mālama ʻana i ke kaumaha lōʻihi. kaulahao aoao.
Hiki ke hoʻohana ʻia e ka subcutaneous injection a i lawe waha ʻia paha.
Ua kūʻai ʻia ma lalo o nā inoa inoa ʻo Ozempic a me Rybelsus no ka maʻi diabetes, a ma lalo o ka inoa inoa ʻo Wegovy no ka pohō kaumaha.
pehea ka maemae ?
hōʻike hōʻike hōʻike hōʻike, he kiʻekiʻe loa prutiy 99.26%,
Hoʻohana lāʻau lapaʻau
Hōʻike ʻia ʻo Semaglutide ma ke ʻano he mea hoʻohui i ka meaʻai a me ka hoʻomaʻamaʻa e hoʻomaikaʻi i ka mana glycemic i nā pākeke me ka maʻi diabetes type 2.
Hōʻike ʻia ka hoʻokumu ʻana o ka semaglutide kiʻekiʻe ma ke ʻano he mea hoʻohui i ka meaʻai a me ka hoʻomaʻamaʻa ʻana no ka mālama ʻana i ke kaumaha lōʻihi i ka poʻe mākua me ka momona (ka helu helu kino kino mua (BMI) ≥ 30 kg / m2) a i ʻole ke kaumaha (BMI mua ≥ 27 kg). /m2) a loaʻa ma ka liʻiliʻi hoʻokahi comorbidity pili i ke kaumaha.
Nā hopena ʻino
ʻO Semaglutide kahi agonist receptor peptide-1 like gcagon.
ʻO nā hopena ʻaoʻao maʻamau, ʻo ia ka nausea, ka luaʻi, ka ʻōpū, ka ʻeha ʻōpū, a me ka constipation.
kekahi huahana like
semaglutide
Tirzepatide
palapala hōʻoia
Retatrutid
Liraglutide
inā makemake ʻoe i nā kikoʻī hou aku e ʻoluʻolu e hoʻomaopopo iaʻu
Ka manawa hoʻouna: Mei-22-2024